Enterprise League logo
Ambros Therapeutics Logo

Ambros Therapeutics

Irvine, United States (US) · Health and Medical

Do you work at Ambros Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Ambros Therapeutics is an Irvine, California-based clinical-stage biotechnology company dedicated to developing transformative medicines for patients suffering from Complex Regional Pain Syndrome Type 1 (CRPS-1).We focus on addressing this devastating rare disease, which causes severe, unrelenting pain following trauma, significantly impacting patients’ quality of life and independence.Our lead investigational program, CRPS-RISE, represents a first-in-class approach utilizing neridronate, a differentiated bisphosphonate, and is currently in a Phase 3 pivotal trial.

Overview

Ambros Therapeutics is an Irvine, California-based clinical-stage biotechnology company dedicated to developing transformative medicines for patients suffering from Complex Regional Pain Syndrome Type 1 (CRPS-1).

We focus on addressing this devastating rare disease, which causes severe, unrelenting pain following trauma, significantly impacting patients’ quality of life and independence.

Our lead investigational program, CRPS-RISE, represents a first-in-class approach utilizing neridronate, a differentiated bisphosphonate, and is currently in a Phase 3 pivotal trial. We are pursuing Breakthrough Therapy, Fast Track, and Orphan Drug designations, reflecting the significant unmet need in this patient population.

Ambros Therapeutics is committed to translating patient experiences into impactful solutions, guided by integrity and scientific rigor.
Visit Official Website

Most teams do this before shortlisting


Contact Details

+1949 508-0173
info@ambrostx.com

Irvine, United States (US), 18575 Jamboree Road

Founded

2024

Company Type

Private Limited Company

Employees

20-30

Categories

Biopharma
Life Science
Biotechnology

Awards

• 2026 OpenSee all

Services

Default Product Image
Neridronate
Biotechnology

Neridronate is a differentiated, third-generation bisphosphonate being developed as a potential disease-modifying therapy for patients with warm CRPS-1. It is the focus of our Phase 3 pivotal trial, CRPS-RISE.

N/A

Companies teams usually look at after Ambros Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.